Mehta, S. http://orcid.org/0000-0003-3741-6918
Parmar, N.
Kelleher, M. http://orcid.org/0000-0003-4637-3454
Jolley, C. J. http://orcid.org/0000-0003-3538-2451
White, P. http://orcid.org/0000-0002-2047-8787
Durbaba, S. http://orcid.org/0000-0002-4098-5399
Ashworth, M.
Article History
Received: 24 March 2019
Accepted: 29 November 2019
First Online: 14 January 2020
Competing interests
: Kelleher M. has received funding from Abbievie, Gilead, Indivior, Reckitt Benckiser, Camerus, and Braeburn pharma. The other authors report no competing interests.